Korea Bio-Gen Co.Ltd (318000) — Cash Flow Quality Index
Korea Bio-Gen Co.Ltd (318000) has a Cash Flow Quality Index of 4.72x as of September 2025. Operating cash flow of ₩1.85 Billion exceeds net income of ₩391.83 Million, indicating high earnings quality where cash backs reported profits. Also explore Korea Bio-Gen Co.Ltd balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Korea Bio-Gen Co.Ltd Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Korea Bio-Gen Co.Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 318000 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Korea Bio-Gen Co.Ltd (2017–2024)
Year-by-year earnings quality comparison for Korea Bio-Gen Co.Ltd. For live market cap and the full company financial profile, see Korea Bio-Gen Co.Ltd (318000) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.14x | ₩4.29 Billion | ₩3.77 Billion | ▼ -44.9% |
| 2023 | 2.07x | ₩9.47 Billion | ₩4.58 Billion | ▲ +302.4% |
| 2022 | 0.51x | ₩1.67 Billion | ₩3.25 Billion | ▼ -33.6% |
| 2021 | 0.77x | ₩3.09 Billion | ₩4.00 Billion | ▼ -6.5% |
| 2020 | 0.83x | ₩2.58 Billion | ₩3.12 Billion | ▲ +6.6% |
| 2018 | 0.78x | ₩1.98 Billion | ₩2.56 Billion | ▲ +3.7% |
| 2017 | 0.75x | ₩1.38 Billion | ₩1.85 Billion | — |